Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Biomarin Pharmaceutical (BMRN) Q3 2019 Earnings
BMRN
+0.99%
1
Aug
Confirmed
Q4 2018
Q1 2019
Q2 2019
Q3 2019
-0.32
-0.22
-0.12
-0.02
Details
Expected EPS
-0.12
Actual EPS
-0.21
Surprise EPS
-0.09
Surprise Percent
+75%
Description
Biomarin Pharmaceutical (BMRN) has reported earnings of -0.21 per share for Q3 2019.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login